期刊文献+

退翳明目中药治疗角膜混浊的研究进展 被引量:5

Progress of Tuiyi Mingmu Chinese medicinals in treatment of corneal opacity
下载PDF
导出
摘要 黑睛发病,局部表现主要是翳障,黑睛生翳即角膜混浊,是指在角膜损伤修复过程中,正常的角膜组织被纤维组织取代,从而影响了角膜的透明度,是一类影响视力甚至致盲的眼病。中医学对其多有论述,针对黑睛生翳,使用具有退翳功效的中药消除翳障,促进黑睛恢复正常状态,是中医眼科治疗黑睛生翳独特的治法。本文通过回顾文献中治疗黑睛生翳所使用的相关中药,发现退翳类中药多归肝经,多寒凉可清热,或兼有补虚的作用。现代药理学研究发现,退翳类中药具有消炎抗菌、抑制瘢痕形成等作用。本文就退翳明目中药治疗黑睛生翳的研究进展予以综述。 The local manifestations of corneal disease are mainly nebula,which is the change of corneal opacity.The normal corneal tissue replaced by fibrotic tissue during wound repair.It is a type of eye disease that affects vision,even leads to blindness.There are many discussions about it in Chinese medicine.Aiming at corneal nebula,promoting the cornea return to normal state,Tuiyi Mingmu Chinese medicinals is a unique therapeutic method of traditional Chinese medicine in the treatment of corneal nebula.This article reviewed the related Chinese medicines used in the literature for the treatment of corneal nebula and found that the Tuiyi Mingmu Chinese medicinals mostly were grouped under the liver meridian,which could clear away heat and replenish deficiency.Modern pharmacological studies have found that Tuiyi Mingmu Chinese medicinals have anti-inflammatory and antibacterial effects and inhibiting scar formation.This article reviewed the research progress of Tuiyi Mingmu Chinese medicinals for the treatment of corneal nebula.
作者 孙宏睿 戴乐舒 叶姗姗 宋剑涛 SUN Hongrui;DAI Leshu;YE Shanshan(Eye Hospital,China Academy of Chinese Medical Sciences,Beijing 100040,China)
出处 《中国中医眼科杂志》 2020年第9期678-680,684,共4页 China Journal of Chinese Ophthalmology
基金 北京市科学技术委员会计划十病十药研发项目(Z161100001816006)。
关键词 黑睛生翳 角膜混浊 退翳明目中药 corneal nebula corneal opacities Tuiyi Mingmu Chinese medicinals
  • 相关文献

参考文献27

二级参考文献266

共引文献497

同被引文献59

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部